eIF4A Antibody

About the Target

eIF4A is a DEAD-box RNA helicase and a prototypic member of the large superfamily 2 (SF2) of helicases. It consists of two α/β domains with a RecA-like topology, which can shift between open and closed conformations. eIF4A's helicase activity, essential for RNA unwinding during translation initiation, is weak on its own but is significantly enhanced when bound to the scaffolding protein eIF4G within the eIF4F complex. Depending on the literature source, eIF4A may also be discussed as eIF4A.

Reported cellular context includes cytoplasm, nucleus, and spliceosome, which can matter when signal is compared across treatments or changing cell states. Following eIF4A across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.

Research Context

eIF4A is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, nucleus, and spliceosome, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm, nucleus, and spliceosome across matched conditions
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• co-patterning with orthogonal markers and control conditions that clarify pathway state
• time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for eIF4A. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in eIF4A reflect biology rather than handling. When interpreting eIF4A, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep eIF4A trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.